16th Mar 2015 08:21
SAN DIEGO (Alliance News) - Illumina Inc said the company and its Verinata Health Inc subsidiary have filed a patent infringement suit against Premaitha Health PLC in the UK High Court of Justice, accusing the British company's IONA Test of infringement, including its use of next-generation sequencing to analyze cell-free fetal DNA from a sample of maternal blood..
Illumina is seeking all available remedies, including damages and injunctive relief.
The patents asserted are European Patent (UK) 0 994 963 B2 and European Patent (UK) 1 981 995 B1, which are exclusively licensed to Illumina from Sequenom Inc and The Board of Trustees of Leland Stanford Junior University, respectively.
Stanford is joined in the suit as a necessary party because it is the registered owner of the European Patent (UK) 1 981 995 B1.
The patents are directed to using cell-free fetal DNA for non-invasive prenatal testing.
Copyright RTT News/dpa-AFX
Related Shares:
Premaitha Health